Navana Pharmaceuticals PLC

Our all facility including General unit has been audited and approved by the Regulatory Authority (DGDA). This unit possesses the establishment of pharmaceutical dosage forms meeting Commercial supply and patient demand. This unit is designed and commissioned as per cGMP guidelines. It provides larger capacity and a stronger platform to manufacture value added generics for Domestic & Global Markets along with offering the company as an attractive manufacturing facility.